BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8626988)

  • 1. Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergies.
    Pauli G; Oster JP; Deviller P; Heiss S; Bessot JC; Susani M; Ferreira F; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 May; 97(5):1100-9. PubMed ID: 8626988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP system in patients with pollen-related allergy to birch and apple.
    Rossi RE; Monasterolo G; Operti D; Corsi M
    Allergy; 1996 Dec; 51(12):940-5. PubMed ID: 9020425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4).
    Mari A; Wallner M; Ferreira F
    Clin Exp Allergy; 2003 Oct; 33(10):1419-28. PubMed ID: 14519150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
    Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance.
    Wensing M; Akkerdaas JH; van Leeuwen WA; Stapel SO; Bruijnzeel-Koomen CA; Aalberse RC; Bast BJ; Knulst AC; van Ree R
    J Allergy Clin Immunol; 2002 Sep; 110(3):435-42. PubMed ID: 12209091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of birch recombinant allergens (rBet v 1, profilin rBet v 2) in children with pollen-related food allergy.
    Cudowska B; Kaczmarski M
    Rocz Akad Med Bialymst; 2004; 49():111-5. PubMed ID: 15631325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.
    Vrtala S; Mayer P; Ferreira F; Susani M; Sehon AH; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):913-21. PubMed ID: 8939154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between IgE antibodies to recombinant allergens rBet v 1 and rBet v 2 and food causing oral allergy syndrome in cases of birch-pollen allergy].
    Yamamoto T; Asakura K; Shirasaki H; Himi T
    Nihon Jibiinkoka Gakkai Kaiho; 2010 Aug; 113(8):661-9. PubMed ID: 20845708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System.
    Movérare R; Elfman L; Vesterinen E; Metso T; Haahtela T
    Allergy; 2002 May; 57(5):423-30. PubMed ID: 11972482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
    van Hage-Hamsten M; Kronqvist M; Zetterström O; Johansson E; Niederberger V; Vrtala S; Grönlund H; Grönneberg R; Valenta R
    J Allergy Clin Immunol; 1999 Nov; 104(5):969-77. PubMed ID: 10550741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1- related PR-10 protein in soybean, SAM22.
    Kleine-Tebbe J; Vogel L; Crowell DN; Haustein UF; Vieths S
    J Allergy Clin Immunol; 2002 Nov; 110(5):797-804. PubMed ID: 12417891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles.
    Rossi RE; Monasterolo G; Monasterolo S
    Allergy; 2003 Sep; 58(9):929-32. PubMed ID: 12911423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population.
    Pauli G; Purohit A; Oster JP; De Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
    Clin Exp Allergy; 2000 Aug; 30(8):1076-84. PubMed ID: 10931114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergens from birch pollen and pollen of the European chestnut share common epitopes.
    Hirschwehr R; Jäger S; Horak F; Ferreira F; Valenta R; Ebner C; Kraft D; Scheiner O
    Clin Exp Allergy; 1993 Sep; 23(9):755-61. PubMed ID: 10779306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How far can we simplify in vitro diagnostics for Fagales tree pollen allergy? A study with three whole pollen extracts and purified natural and recombinant allergens.
    Van Ree R; Van Leeuwen WA; Akkerdaas JH; Aalberse RC
    Clin Exp Allergy; 1999 Jun; 29(6):848-55. PubMed ID: 10336603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
    Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
    J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization to cross-reactive carbohydrate determinants and the ubiquitous protein profilin: mimickers of allergy.
    Ebo DG; Hagendorens MM; Bridts CH; De Clerck LS; Stevens WJ
    Clin Exp Allergy; 2004 Jan; 34(1):137-44. PubMed ID: 14720274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific IgE to recombinant vegetal panallergen (rBet v 2) and fruit allergy in pollinic patients.
    Daschner A; Crespo JF; Pascual CY
    Allergy; 1998 Jun; 53(6):614-8. PubMed ID: 9689344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fruit-pollen-latex cross-reactivity: implication of profilin (Bet v 2).
    Díez-Gómez ML; Quirce S; Cuevas M; Sánchez-Fernández C; Baz G; Moradiellos FJ; Martínez A
    Allergy; 1999 Sep; 54(9):951-61. PubMed ID: 10505458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of clinical markers of sensitization to profilin in patients allergic to plant-derived foods.
    Asero R; Mistrello G; Roncarolo D; Amato S; Zanoni D; Barocci F; Caldironi G
    J Allergy Clin Immunol; 2003 Aug; 112(2):427-32. PubMed ID: 12897752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.